DE69300913D1 - Polymorph Terazosin und pharmazeutische Zusammenstellung. - Google Patents
Polymorph Terazosin und pharmazeutische Zusammenstellung.Info
- Publication number
- DE69300913D1 DE69300913D1 DE69300913T DE69300913T DE69300913D1 DE 69300913 D1 DE69300913 D1 DE 69300913D1 DE 69300913 T DE69300913 T DE 69300913T DE 69300913 T DE69300913 T DE 69300913T DE 69300913 D1 DE69300913 D1 DE 69300913D1
- Authority
- DE
- Germany
- Prior art keywords
- terazosin
- polymorph
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5491793A | 1993-04-29 | 1993-04-29 | |
US08/090,721 US5294615A (en) | 1993-04-29 | 1993-07-13 | Terazosin polymorph and pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69300913D1 true DE69300913D1 (de) | 1996-01-11 |
DE69300913T2 DE69300913T2 (de) | 1996-05-02 |
Family
ID=26733641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69300913T Revoked DE69300913T2 (de) | 1993-04-29 | 1993-09-28 | Polymorph Terazosin und pharmazeutische Zusammenstellung. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5294615A (de) |
EP (1) | EP0623612B1 (de) |
JP (1) | JP2755895B2 (de) |
DE (1) | DE69300913T2 (de) |
DK (1) | DK0623612T3 (de) |
ES (1) | ES2089665T3 (de) |
GR (1) | GR3018433T3 (de) |
HK (1) | HK124397A (de) |
MX (1) | MX9306196A (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5596109A (en) * | 1992-03-24 | 1997-01-21 | Smithkline Beecham Corporation | N-t-butyl-androst-3,5-diene-17β-carboxamide-3-carboxylic acid polymorph A |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
US5587377A (en) * | 1995-10-24 | 1996-12-24 | Invamed, Inc. | Terazosin crystalline polymorph and pharmaceutical compositions thereof |
DE19546573A1 (de) * | 1995-12-13 | 1997-06-19 | Uetikon Chemie Gmbh | Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung |
US5952003A (en) * | 1996-08-01 | 1999-09-14 | Novartis Corporation | Terazosin capsules |
IT1286790B1 (it) * | 1996-11-29 | 1998-07-17 | Alfa Chem Ital | Processo per la produzione della forma i del terazosin monocloridrato anidro |
IT1286789B1 (it) * | 1996-11-29 | 1998-07-17 | Alfa Chem Ital | Processo per la produzione della forma i del terazosin monocloridato anidro |
EP0849264A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von doxazosinmesylat (Form I) |
PT849266E (pt) * | 1996-12-20 | 2007-03-30 | Heumann Pcs Gmbh | Nova forma polimorfa de mesilato de doxazosina (forma iii) |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
US6248888B1 (en) | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
ES2435816T3 (es) * | 1999-08-03 | 2013-12-23 | Icos Corporation | Formulación farmacéutica que comprende una Beta-carbolina y su uso para el tratamiento de la disfunción sexual |
US6200573B1 (en) | 1999-12-03 | 2001-03-13 | Starcor Pharmaceuticals, Inc. | Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
DE10000792A1 (de) * | 2000-01-11 | 2001-07-19 | Bernhard C Lippold | Formulierungen von Wirkstoffen in Form einer festen Dispersion |
JP2005538031A (ja) * | 2000-11-17 | 2005-12-15 | イーライ・リリー・アンド・カンパニー | ラクタム化合物 |
US20030138483A1 (en) * | 2001-05-25 | 2003-07-24 | Sergio Petriconi | Soft elastic capsules and compositions thereof |
US8496960B2 (en) * | 2001-10-23 | 2013-07-30 | Purdue Pharma L.P. | Terazosin transdermal device and methods |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
TWI353979B (en) | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
US7097967B2 (en) * | 2002-10-24 | 2006-08-29 | Lg Life Sciences Ltd. | Method of predicting drug-food interaction |
KR20040076203A (ko) * | 2003-02-24 | 2004-08-31 | 주식회사 엘지생명과학 | 음식물-약물 상호작용을 방지하기 위한 경구 투여용약제학적 조성물 및 방법 |
AU2007286186A1 (en) * | 2006-08-08 | 2008-02-21 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
CN102321563B (zh) | 2011-10-24 | 2013-04-03 | 江南大学 | 一株拟无枝酸菌及利用其全细胞转化制备香草醛的方法 |
US9096428B2 (en) * | 2013-03-08 | 2015-08-04 | Taiwan Semiconductor Manufacturing Company, Ltd. | Methods and apparatus for MEMS structure release |
US11224572B1 (en) | 2020-08-17 | 2022-01-18 | Novitium Pharma LLC | Stable oral liquid composition of terazosin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
US5122514A (en) * | 1990-04-23 | 1992-06-16 | Abbott Laboratories | Psoriasis treatment |
US5212176A (en) * | 1990-06-29 | 1993-05-18 | Abbott Laboratories | R(+)-terazosin |
JP2652272B2 (ja) * | 1990-12-31 | 1997-09-10 | 住化ファインケム株式会社 | 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法 |
-
1993
- 1993-07-13 US US08/090,721 patent/US5294615A/en not_active Expired - Fee Related
- 1993-09-28 DE DE69300913T patent/DE69300913T2/de not_active Revoked
- 1993-09-28 EP EP93115607A patent/EP0623612B1/de not_active Revoked
- 1993-09-28 DK DK93115607.9T patent/DK0623612T3/da active
- 1993-09-28 ES ES93115607T patent/ES2089665T3/es not_active Expired - Lifetime
- 1993-10-05 MX MX9306196A patent/MX9306196A/es not_active IP Right Cessation
- 1993-10-14 JP JP5257010A patent/JP2755895B2/ja not_active Expired - Lifetime
-
1994
- 1994-01-06 US US08/178,184 patent/US5362730A/en not_active Expired - Fee Related
-
1995
- 1995-12-15 GR GR950403563T patent/GR3018433T3/el unknown
-
1997
- 1997-06-26 HK HK124397A patent/HK124397A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3018433T3 (en) | 1996-03-31 |
HK124397A (en) | 1997-09-12 |
US5294615A (en) | 1994-03-15 |
US5362730A (en) | 1994-11-08 |
EP0623612A1 (de) | 1994-11-09 |
JP2755895B2 (ja) | 1998-05-25 |
DK0623612T3 (da) | 1996-02-05 |
EP0623612B1 (de) | 1995-11-29 |
JPH06312984A (ja) | 1994-11-08 |
ES2089665T3 (es) | 1996-10-01 |
DE69300913T2 (de) | 1996-05-02 |
MX9306196A (es) | 1994-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69300913D1 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
FI944832A0 (fi) | Farmaseuttinen koostumus | |
DE69618587D1 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
FI954767A (fi) | Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus | |
ATA129892A (de) | Pharmazeutische zusammensetzung | |
DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
BR9713237B1 (pt) | comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo. | |
NO962606D0 (no) | Farmasöytisk sammensetning | |
BR1100824A (pt) | Composto e composição farmacêutica | |
BR9607851B1 (pt) | combinaÇço e formulaÇço farmacÊutica. | |
BR9408457A (pt) | Preparação farmacêutica percutânia | |
DE69524592D1 (de) | 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung | |
ITMI932540A0 (it) | Composizione farmaceutica | |
DE4294862T1 (de) | Pharmazeutische Komposition | |
BR9509688A (pt) | Composto e composição farmacêutica | |
DE69614407D1 (de) | Pharmazeutische zusammensetzungen | |
LV11727A (lv) | Farmaceitiska kompozicija | |
DE69434210D1 (de) | Pharmazeutische antacidzusammensetzung | |
FI973280A (fi) | Farmaseuttinen koostumus | |
LV10579A (lv) | Farmaceitiska kompozicija | |
DE69509621D1 (de) | Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung | |
BR9605777A (pt) | Composição farmacêutica | |
BR9605131A (pt) | Composição farmacêutica | |
DE69003003D1 (de) | Pharmazeutische Zusammensetzung. | |
BR1101082A (pt) | Composto, e, composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |